Patents by Inventor Vijay PRAJAPATI

Vijay PRAJAPATI has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Short-chain peptides as Kappa (?) opioid receptors (KOR) agonist
    Patent number: 10550150
    Abstract: The present invention relates to novel short-chain peptides of the general formula (I), which are selective and peripherally acting KOR agonist, their tautomeric forms, their enantiomers, their diastereoisomers, their stereoisomers, their pharmaceutically accepted salts, or prodrugs thereof which are useful in the treatment or prevention of diseases in which the Kappa (?) opioid receptors (KOR) are involved, such as treatment or prevention of visceral pain, hyperalgesia, rheumatoid arthritic inflammation, osteoarthritic inflammation, IBD inflammation, IBS inflammation, ocular inflammation, otitic inflammation or autoimmune inflammation. The invention also relates to process for the manufacture of said short-chain peptides, and pharmaceutical compositions containing them and their use.
    Type: Grant
    Filed: May 9, 2016
    Date of Patent: February 4, 2020
    Assignee: CADILA HEALTHCARE LIMITED
    Inventors: Ranjit Desai, Rajesh Bahekar, Vijay Prajapati, Rajendra Chopade
  • NOVEL SHORT-CHAIN PEPTIDES AS KAPPA (κ) OPIOID RECEPTORS (KOR) AGONIST
    Publication number: 20180282369
    Abstract: The present invention relates to novel short-chain peptides of the general formula (I), which are selective and peripherally acting KOR agonist, their tautomeric forms, their enantiomers, their diastereoisomers, their stereoisomers, their pharmaceutically accepted salts, or prodrugs thereof which are useful in the treatment or prevention of diseases in which the Kappa (?) opioid receptors (KOR) are involved, such as treatment or prevention of visceral pain, hyperalgesia, rheumatoid arthritic inflammation, osteoarthritic inflammation, IBD inflammation, IBS inflammation, ocular inflammation, otitic inflammation or autoimmune inflammation. The invention also relates to process for the manufacture of said short-chain peptides, and pharmaceutical compositions containing them and their use.
    Type: Application
    Filed: May 9, 2016
    Publication date: October 4, 2018
    Inventors: Ranjit DESAI, Rajesh BAHEKAR, Vijay PRAJAPATI, Rajendra CHOPADE
  • NOVEL HETEROBICYCLIC COMPOUNDS AS KAPPA OPIOID AGONISTS
    Publication number: 20170007610
    Abstract: The present invention relates to novel compounds of the general formula (I), which are selective and peripherally acting KOR agonist, their tautomeric forms, their enantiomers, their diastereoisomers, their stereoisomers, their pharmaceutically accepted salts, or prodrugs thereof which are useful in the treatment or prevention of diseases in which the Kappa (?) opioid receptors (KOR) are involved, such as treatment or prevention of visceral pain, hyperalgesia, rheumatoid arthritic inflammation, osteoarthritic inflammation, IBD inflammation, IBS inflammation, ocular inflammation, otitic inflammation or autoimmune inflammation. The invention also relates to process for the manufacture of said compounds, and pharmaceutical compositions containing them and their use.
    Type: Application
    Filed: January 23, 2015
    Publication date: January 12, 2017
    Inventors: Ranjit C. DESAI, Rajesh BAHEKAR, Vijay PRAJAPATI, Pankaj R. PATEL